Global Women’s Digital Health Market Forecast 2025–2032 Added to ResearchAndMarkets.com ResearchAndMarkets.com has announced the addition of its latest industry report, “Women’s Digital Health Market – Global Forecast 2025–2032,” offering an in-depth analysis of one of the fastest-growing segments within the…
Spinol Medical™ Advances OctaSeal™ Annular Closure System Into FDA Review, Introducing a Minimally Invasive Intradiscal Solution Supported by Five-Year Clinical Data Spinol Medical™ today announced that its OctaSeal™ Annular Closure System has advanced into formal review by the U.S. Food…
Ge Health Care–indonesia Sihren Ct Scanner Expansion GE HealthCare to Deploy More Than 300 Advanced CT Scanners Across Indonesia Under Landmark SIHREN Program Indonesia GE HealthCare has announced a major, multi-year collaboration with Indonesia’s Ministry of Health to significantly expand…
HealthStream Expands Workforce Ecosystem with Acquisition of MissionCare Collective, Strengthening Caregiver Career Networks Nationwide HealthStream, a leading healthcare technology company specializing in workforce development solutions, today announced the acquisition of MissionCare Collective LLC (“MissionCare”), a healthcare workforce organization recognized for…
GenSci, RTW Investments, and Yarrow Bioscience Enter Strategic Global Partnership to Advance First-in-Class Anti-TSHR Antibody for Graves’ Disease and Thyroid Eye Disease SHANGHAI & NEW YORK Shanghai Scizeng Medical Technology Co LTD, a subsidiary of Changchun GeneScience Pharmaceutical (“GenSci”), together…
Washington State Expands Access to Life-Saving Medications for Opioid Use Disorder with New Provider Resource Library In a major step forward in Washington State’s ongoing response to the opioid crisis, the Washington State Health Care Authority (HCA) and the Department…
PDUFA Date Extended for Aldeyra’s Reproxalap Dry Eye NDA Aldeyra Therapeutics a biotechnology company focused on the discovery and development of innovative therapies for immune-mediated and inflammatory diseases, has announced that the U.S. Food and Drug Administration (FDA) has extended…
Natera and MEDSIR Partner on MiRaDoR Trial to Advance Genome-Guided Treatment Strategies in HR+/HER2- Breast Cancer Natera a global leader in cell-free DNA (cfDNA) testing and precision medicine, and MEDSIR (Medica Scientia Innovation Research), an international clinical research organization specializing…
Innoviva Specialty Therapeutics, a subsidiary of Innoviva, today announced that the U.S. Food and Drug Administration (FDA) has approved NUZOLVENCE (zoliflodacin) for oral suspension, a first-in-class, single-dose oral antibiotic for the treatment of uncomplicated urogenital gonorrhea in adults and adolescents…
Research And Markets has announced the addition of the “Diabetic Neuropathy Market Report: Trends, Forecast and Competitive Analysis to 2031” to its expanding portfolio of healthcare and life sciences market intelligence reports. According to the report, the global diabetic neuropathy…
